{"id":"W1814034318","doi":"10.1016/s0140-6736(15)61117-5","title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Health Canada; Norges Forskningsråd; U.S. Department of Defense; European Commission; World Health Organization; Department for International Development, UK Government; Public Health Agency of Canada; Wellcome Trust; Canadian Institutes of Health Research; Médecins Sans Frontières; Wellcome; Utenriksdepartementet; Bill and Melinda Gates Foundation; International Development Research Centre","keywords":"Ebola vaccine; Ebola virus; Medicine; Vaccination; Virology; Immunology; Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}